Home > Boards > Free Zone > Industry Specific > Cannabis Investment Club

"A New ETF Launches for Next-Gen Medicine":

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DarthYoda Member Profile
Member Level 
Followed By 122
Posts 12,248
Boards Moderated 3
Alias Born 09/05/13
160x600 placeholder
VC Daily: ShouTi Lands $100 Million to Develop Pills for Chronic Diseases
Good day. Venture capitalists are funneling $100 million into biotechnology company's ShouTi Inc.'s effort to turn injected medicines into oral pills.
Exxon Plans $400 Million Expansion of Carbon Capture Facility in Wyoming
Soybean Sales Perk Up
Philly's Fed District Manufacturing Activity Eased in October
Fed's Quarles Warns of Extended High Inflation; Paycheck Protection Program May Have Made Inequality Worse, Minneapolis Fed Chief Says
U.S. Jobless Claims Fell 6K to 290K in Oct. 16 Week
Sio Gene Therapies Gets FDA Fast-Track Designation for AXO-AAV-GM1 in GM1 Gangliosidosis
Union Pacific Earnings Grow, With Revenue Carloads Flat
Essential Utilities to Buy City of Beaver Falls Municipal Wastewater Assets
Intellia Gets FDA Orphan Designation for NTLA-2001 in ATTR Amyloidosis
Pfizer, BioNTech: Phase 3 Study Shows High Efficacy of Covid-19 Vaccine Booster
Marsh & McLennan 3Q Profit Rises
Turkish Central Bank Cuts Benchmark Interest Rate to 16% -- Update
Turkish Central Bank Cuts Benchmark Interest Rate to 16%
High Consumer Vehicle Demand Drives AutoNation's 3Q Profit, Sales Higher
Top Company News of the Day
OGDCL Discovers Gas at Jandran West X-1 Well in Pakistan
Atlas Copco Posts Smaller-Than-Expected Rise in 3Q Net Profit
Danaher Sees Core Sales Growth of More Than 20% in 2021
Dow Inc. Revenue Gains in 3Q Support Swing to Profit
Danaher 3Q Sales, Profits Grow, Lifted by Covid-19 Work
Sterling Expected to Gain on UK Recovery, BOE Rate Rises
Stocks Drop on Economic Uncertainty, Evergrande Troubles
North American Morning Briefing:Stock Futures Edge Lower as Evergrande Worries Resurface
FTSE 100 Lower as Investors Fret Over Evergrande
Lancashire Holdings Warns on Political, Natural Catastrophe Losses
Norway's Oil Fund Returned 0.1% in 3Q
TSMC's Arizona Unit to Issue $4.5 Billion Senior Unsecured Notes
Aker Solutions Gets Contract for Work on Floating, Production, Storage and Offloading Vessel
EQT, Vitruvian Partners Invest in Specialist Insurer CFC
Correction to Barclays Earnings Article on Thursday
UK Public Borrowing Likely to Keep Undershooting Official Forecasts
DarthYoda Member Level  Tuesday, 06/01/21 12:51:11 PM
Re: JohnCM post# 2056
Post # of 2155 
"A New ETF Launches for Next-Gen Medicine":
May 31, 2021
Quote:
According to a report from ResearchAndMarkets, the global psychedelic drugs market could be worth $10.75 billion by 2027. And until then, it will grow at a compounded annual growth rate of more than 12%.

The sector is still in its infancy stages, which it makes it both very promising and risky. One way for investors to hedge some of that risk is to invest in an exchange-traded fund (ETF) that gives them some broad exposure. And Defiance Next Gen Altered Experience ETF (NYSEArca:PSY) can accomplish just that. It is the first psychedelic ETF to trade in the U.S. and launched just last week. However, the fund goes beyond just psychedelics.

Defiance ETFs says that investors will get "exposure to companies involved in the development of the next generation of medicine, including psychedelics, cannabis and other psychedelic derived treatments."

The top two stocks in the fund are from the cannabis sector as both Charlotte's Web (TSX:CWEB) and Aurora Cannabis (TSX:ACB)(NASDAQ:ACB) make up more than 7% of the fund's net assets. Psychedelics stock Compass Pathways (NASDAQ:CMPS) is also in the fund and at the number five spot, with a weight of about 5.6%. Mind Medicine (NASDAQ:MNMD) is a few spots further down.

However, the makeup of the ETF likely change as more psychedelic companies go public. Currently, there are just 20 holdings in the fund so investors won't get a whole lot of diversification just yet; in larger funds, stocks can make up just 1% or 2% of the total holdings.

The Next Gen Altered Experience ETF charges an expense ratio of 0.75%.


https://ca.finance.yahoo.com/news/etf-launches-next-gen-medicine-151400018.html

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences